Trial reportIntensive care medicine2013
Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events.
Trial report in Intensive care medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04699682 (Carriage Clearance of Emerging Highly Resistant Bacteria in Chronic Dialysis Patients), which is not on this map. Cited by 29 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Carriage Clearance of Emerging Highly Resistant Bacteria in Chronic Dialysis Patients
Who cites it
29 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Is systematic fecal carriage screening of extended-spectrum beta-lactamase-producing Enterobacteriaceae still useful in intensive care unit: a systematic review.Critical care (London, England) · 2019Pooled it
- Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital setting.The Cochrane database of systematic reviews · 2015Pooled it
- Machine Learning Models to Establish the Risk of Being a Carrier of Multidrug-Resistant Bacteria upon Admission to the ICU.Antibiotics (Basel, Switzerland) · 2025Article
- Article
- Understanding and mitigating medication errors associated with patient harm in adult intensive care units: a scoping review.Intensive care medicine · 2025Article
- End-of-Life Infections and the Dilemma of Emerging Antimicrobial Resistance: A Scoping Review.Infection & chemotherapy · 2025Review
- Doff Thy Gown-Shedding Contact Precautions for COVID-19.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024Article
- Five-Hour Detection of Intestinal Colonization with Extended-Spectrum-β-Lactamase-ProducingMicrobiology spectrum · 2023Article
- Limiting the Spread of Multidrug-Resistant Bacteria in Low-to-Middle-Income Countries: One Size Does Not Fit All.Pathogens (Basel, Switzerland) · 2023Review
- Impact of Isolation Time of COVID-19 Patients in Intensive Care Unit on Healthcare Workers Contamination and Nursing Care Intensity.Frontiers in medicine · 2022Article
- Article
- Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH).Scientific reports · 2021Article
- Higher incidence of adverse events in isolated patients compared with non-isolated patients: a cohort study.BMJ open · 2020Article
- Less contact isolation is more in the ICU: pro.Intensive care medicine · 2020Article
- Psychological outcomes of MRSA isolation in spinal cord injury rehabilitation.Spinal cord series and cases · 2020Article
- Pathogenesis-Targeted Preventive Strategies for Multidrug Resistant Ventilator-Associated Pneumonia: A Narrative Review.Microorganisms · 2020Review
- Multidrug-resistant bacteria in a paediatric palliative care inpatient unit: results of a one year surveillance.GMS hygiene and infection control · 2020Article
- Antibiotic stewardship and horizontal infection control are more effective than screening, isolation and eradication.Infection · 2018Review
- Article
- Understanding why resistant bacteria are associated with higher mortality in ICU patients.Intensive care medicine · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
unlabelledContact isolation of infected or colonised hospitalised patients is instrumental to interrupting multidrug-resistant organism (MDRO) cross-transmission. Many studies suggest an increased rate of adverse events associated with isolation. We aimed to compare isolated to non-isolated patients in intensive care units (ICUs) for the occurrence of adverse events and medical errors.
methodsWe used the large database of the Iatroref III study that included consecutive patients from three ICUs to compare the occurrence of pre-defined medical errors and adverse events among isolated vs. non-isolated patients. A subdistribution hazard regression model with careful adjustment on confounding factors was used to assess the effect of patient isolation on the occurrence of medical errors and adverse events.
resultsTwo centres of the Iatroref III study were eligible, an 18-bed and a 10-bed ICU (nurse-to-bed ratio 2.8 and 2.5, respectively), with a total of 1,221 patients. After exclusion of the neutropenic and graft transplant patients, a total of 170 isolated patients were compared to 980 non-isolated patients. Errors in insulin administration and anticoagulant prescription were more frequent in isolated patients. Adverse events such as hypo- or hyperglycaemia, thromboembolic events, haemorrhage, and MDRO ventilator-associated pneumonia (VAP) were also more frequent with isolation. After careful adjustment of confounders, errors in anticoagulant prescription [subdistribution hazard ratio (sHR) = 1.7, p = 0.04], hypoglycaemia (sHR = 1.5, p = 0.01), hyperglycaemia (sHR = 1.5, p = 0.004), and MDRO VAP (sHR = 2.1, p = 0.001) remain more frequent in isolated patients.
conclusionContact isolation of ICU patients is associated with an increased rate of some medical errors and adverse events, including non-infectious ones.
Indexed as
Identifiers
23995982What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.